Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies

The present study sought to elucidate the prognosis of adult T‐cell leukemia–lymphoma (ATL) patients receiving mogamulizumab, a defucosylated anti‐CCR4 monoclonal antibody. Progression‐free survival (PFS) and overall survival (OS) of ATL patients enrolled in two studies are herein updated, namely NC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Takashi, Utsunomiya, Atae, Jo, Tatsuro, Yamamoto, Kazuhito, Kato, Koji, Yoshida, Shinichiro, Takemoto, Shigeki, Suzushima, Hitoshi, Kobayashi, Yukio, Imaizumi, Yoshitaka, Yoshimura, Kenichi, Kawamura, Kouichi, Takahashi, Takeshi, Tobinai, Kensei, Ueda, Ryuzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623751/
https://www.ncbi.nlm.nih.gov/pubmed/28776876
http://dx.doi.org/10.1111/cas.13343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623751/
https://www.ncbi.nlm.nih.gov/pubmed/28776876
http://dx.doi.org/10.1111/cas.13343

Ejemplares similares